Home » Clinical Trials » Search Clinical Trials

Therapeutic Areas: Neurology

Memory Problems Clinical Trials

A listing of Memory Problems medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Xenoscience
Phoenix Arizona 85004

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Territory Neurology & Research Institute
Tucson Arizona 85704

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

California

Alliance Research Center
Laguna Hills California 92653

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Collaborative Neuro Science Network
Long Beach California 90806

Clinical study evaluating treatment for Alzheimer's disease

Renew Behavioral Health, Inc.
Long Beach California 90807

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A 24-month, multi-center, double-blind, randomized, placebo-controlled Medical food study for the efficacy of Vayacog® in Mild Cognitive Impairment (MCI), "PROTECT"

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

A 24-month, multi-center, double-blind, randomized, placebo-controlled Medical food study for the efficacy of Vayacog® in Mild Cognitive Impairment (MCI), "PROTECT"

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease

Excell Research, Inc.
Oceanside California 92056

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Asclepes Research Center
Panorama City California 91402

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Northern California Research
Sacramento California 95821

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Sharp Mesa Vista Hospital Clinical Research Center
San Diego California 92123

A Study of LY3314814 in Participants With Mild Alzheimer's Disease Dementia (DAYBREAK-ALZ)

Connecticut

Chase Medical Research, LLC
Waterbury Connecticut 06708

AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext (NOURISH AD)

Florida

Bradenton Research Center
Bradenton Florida 34205

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

IMIC, Inc.
Miami Florida 33157

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Panax Clincial Research LLC
Miami Lakes Florida 33014

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Neurostudies, Inc.
Port Charlotte Florida 33952

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Progressive Medical Research
Port Orange Florida 32127

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

University of South Florida - USF Health Psychiatry Center
Tampa Florida 33613

A Multi-center, Double-blind, Randomized, Placebo-controlled Study for the Efficacy of Phosphatidylserine in Mild Cognitive Impairment (MCI)

Stedman Clinical Trials
Tampa Florida 33613

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Georgia

NeuroStudies.net, LLC
Decatur Georgia 30033

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study of Crenezumab in Patients With Prodromal to Mild Alzheimer's Disease

NeuroStudies.net, LLC
Decatur Georgia 30033

A Placebo-Controlled, Double-Blind, Parallel-Group, 24 Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease

NeuroStudies.net, LLC
Decatur Georgia 30033

An exploratory, paired biomarker study in subjects with Alzheimer's disease vs. healthy subjects

Illinois

Behavioral Health Care Associates
Schaumburg Illinois 60193

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Maine

Eastern Maine Medical Center
Bangor Maine 04401

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Massachusetts

ActiveMed
Methuen Massachusetts 01844

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Michigan

Bronson Neurobehavioral Health
Paw Paw Michigan 49079

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Missouri

Clinical Research Professionals, LLC
Chesterfield Missouri 63141

Early Alzheimer's Disease Clinical Research Study

New Hampshire

ActiveMed
Portsmouth New Hampshire 03801

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

New Jersey

Memory Enhancement Center of America
Eatontown New Jersey 07724

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Premier Urology Associates, LLC
Lawrenceville New Jersey 08648

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

The NeuroCognitive Institute
Mt. Arlington New Jersey 07856

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

New Mexico

Albuquerque Neuroscience
Albuquerque New Mexico 87109

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

New York

SPRI Clinical Trials Brooklyn
Brooklyn New York 11235

A clinical research study to evaluate the added benefit of an investigational drug in people with moderate Alzheimer’s disease who are currently taking stable doses of Donepezil and either Memantine or Namenda XR.

SPRI Clinical Trials Brooklyn
Brooklyn New York 11235

An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease (AMARANTH)

Parker Jewish Institute
New Hyde Park New York 11040

A Phase 3, double blind, randomized study of RVT-101 versus placebo when added to existing stable donepezil treatment in subjects with mild to moderate Alzheimer’s disease; RVT-101-3001

Medical Research Network
New York New York 10128

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Manhattan Behavioral Medicine
New York New York 10023

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Winifred Masterson Burke Medical Research Institute
White Plains New York 10605

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

North Carolina

ANI Neurology, PLLC Alzheimer's Memory Center
Charlotte North Carolina 28270

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

PMG Research of Winston-Salem
Winston-Salem North Carolina 27103

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Ohio

Columbus Research & Wellness Institute
Columbus Ohio 31904

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Oklahoma

Cutting Edge Research Group
Oklahoma City Oklahoma 73116

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Tulsa Clinical Research, Inc.
Tulsa Oklahoma 74114

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Pennsylvania

Pearl Clinical Research
Norristown Pennsylvania 19401

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Thomas Jefferson University
Philadelphia Pennsylvania 19107

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

South Carolina

Metrolina Neurological Associates, PA
Rock Hill South Carolina 29732

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Tennessee